-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JHQHO36BWxR4MvXEzVq3UuXuCwd+UZY6IZXTis8wpbY4QSpV4phxM3xVgYlROpZV 3DOG1HKtPYBU7D1iigCc7w== 0001144204-10-018164.txt : 20100401 0001144204-10-018164.hdr.sgml : 20100401 20100401201448 ACCESSION NUMBER: 0001144204-10-018164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100330 FILED AS OF DATE: 20100401 DATE AS OF CHANGE: 20100401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PRESSURE BIOSCIENCES INC CENTRAL INDEX KEY: 0000830656 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 042652826 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14 NORFOLK AVENUE CITY: SOUTH EASTON STATE: MA ZIP: 02375 BUSINESS PHONE: 5085801818 MAIL ADDRESS: STREET 1: 14 NORFOLK AVENUE CITY: SOUTH EASTON STATE: MA ZIP: 02375 FORMER COMPANY: FORMER CONFORMED NAME: BOSTON BIOMEDICA INC DATE OF NAME CHANGE: 19960812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FRITZSCHE R WAYNE CENTRAL INDEX KEY: 0001029493 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21615 FILM NUMBER: 10726348 MAIL ADDRESS: STREET 1: 835 GREENS PARKWAY, SUITE 150 CITY: HOUSTON STATE: TX ZIP: 77067 4 1 form430219_040110201426-.xml X0303 4 2010-03-30 0 0000830656 PRESSURE BIOSCIENCES INC PBIO 0001029493 FRITZSCHE R WAYNE 1311 TRAIL GLEN LANE LUTZ FL US 33549 1 0 0 0 Series A Convertible Preferred Stock 0 2010-03-30 4 M 0 761 12.5 A 2009-02-12 Common Stock 7610 28059 D 15-Month Preferred Stock Purchase Warrant 12.5 2010-03-30 4 M 0 2475 0 D 2009-02-12 2010-05-12 Common Stock 24750 2475 D The terms of the Series A Convertible Preferred Stock contain a limitation on conversion which prevents the Reporting Person from converting shares of Series A Convertible Preferred Stock into shares of Common Stock if, after giving effect to the conversion, the Reporting Person would beneficially own more than 4.99% of the outstanding shares of Common Stock. The Reporting Person may elect to increase this limitation to 9.99%, 14.99% or 19.99%, upon not less than 61 days prior written notice to the Company. The Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest in such securities. The Series A Convertible Preferred Stock has no expiration date. The individual elected cashless exercise as allowed by affiliates of the Company, thereby receiving fewer preferred shares. Richard T. Schumacher, Attorney in Fact 2010-04-01 -----END PRIVACY-ENHANCED MESSAGE-----